{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:51:08Z","timestamp":1791424268978,"version":"4.3.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T00:00:00Z","timestamp":1436054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00213-015-3995-x","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T19:54:13Z","timestamp":1435953253000},"page":"3431-3441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL\/6J mice"],"prefix":"10.1007","volume":"232","author":[{"given":"Tamzin L.","family":"Ripley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Sanchez-Roige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Bullmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolo","family":"Mugnaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Maltby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Wille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,5]]},"reference":[{"key":"3995_CR1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2174\/138161211795656774","volume":"17","author":"LA Berner","year":"2011","unstructured":"Berner LA, Bocarsly ME, Hoebel BG, Avena NM (2011) Pharmacological interventions for binge eating: lessons from animal models, current treatments, and future directions. Curr Pharm Des 17:1180\u20131187","journal-title":"Curr Pharm Des"},{"key":"3995_CR2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pbb.2010.04.020","volume":"96","author":"EE Codd","year":"2010","unstructured":"Codd EE, Ma JY, Zhang SP, Stone DJ, Colburn RW, Brandt MR, Chevalier KM, Zhu YX, Peng S, Cai CZ, Acton PD, Flores CM (2010) Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose range. Pharmacol Biochem Behav 96:130\u2013135","journal-title":"Pharmacol Biochem Behav"},{"key":"3995_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s002130051085","volume":"146","author":"H Wit de","year":"1999","unstructured":"de Wit H, Svenson J, York A (1999) Non-specific effect of naltrexone on ethanol consumption in social drinkers. Psychopharmacology (Berl) 146:33\u201341","journal-title":"Psychopharmacology (Berl)"},{"key":"3995_CR4","doi-asserted-by":"crossref","unstructured":"Donoghue K, Elzerbi C, Saunders R, Whittington C, Pilling S, Drummond C (2015) The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the Rest of the World: a meta-analysis. Addiction","DOI":"10.1111\/add.12875"},{"key":"3995_CR5","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/npp.2012.128","volume":"37","author":"C Giuliano","year":"2012","unstructured":"Giuliano C, Robbins TW, Nathan PJ, Bullmore ET, Everitt BJ (2012) Inhibition of opioid transmission at the mu-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology 37:2643\u20132652","journal-title":"Neuropsychopharmacology"},{"key":"3995_CR6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-012-2949-9","volume":"227","author":"C Giuliano","year":"2013","unstructured":"Giuliano C, Robbins TW, Wille DR, Bullmore ET, Everitt BJ (2013) Attenuation of cocaine and heroin seeking by mu-opioid receptor antagonism. Psychopharmacology (Berl) 227:137\u2013147","journal-title":"Psychopharmacology (Berl)"},{"key":"3995_CR7","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1530-0277.2011.01545.x","volume":"35","author":"LS Hwa","year":"2011","unstructured":"Hwa LS, Chu A, Levinson SA, Kayyali TM, DeBold JF, Miczek KA (2011) Persistent escalation of alcohol drinking in C57BL\/6J mice with intermittent access to 20% ethanol. Alcohol Clin Exp Res 35:1938\u20131947","journal-title":"Alcohol Clin Exp Res"},{"key":"3995_CR8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/jpet.111.180943","volume":"339","author":"DM Ignar","year":"2011","unstructured":"Ignar DM, Goetz AS, Noble KN, Carballo LH, Stroup AE, Fisher JC, Boucheron JA, Brainard TA, Larkin AL, Epperly AH, Shearer TW, Sorensen SD, Speake JD, Hommel JD (2011) Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist. J Pharmacol Exp Ther 339:24\u201334","journal-title":"J Pharmacol Exp Ther"},{"key":"3995_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02244836","volume":"114","author":"GH Jones","year":"1994","unstructured":"Jones GH, Schneider C, Schneider HH, Seidler J, Cole BJ, Stephens DN (1994) Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies. Psychopharmacology (Berl) 114:191\u2013199","journal-title":"Psychopharmacology (Berl)"},{"key":"3995_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-007-0711-5","volume":"192","author":"NK Kamdar","year":"2007","unstructured":"Kamdar NK, Miller SA, Syed YM, Bhayana R, Gupta T, Rhodes JS (2007) Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL\/6J mice. Psychopharmacology (Berl) 192:207\u2013217","journal-title":"Psychopharmacology (Berl)"},{"key":"3995_CR11","doi-asserted-by":"crossref","unstructured":"Kelly E, Mundell SJ, Sava A, Roth AL, Felici A, Maltby K, Nathan PJ, Bullmore ET, Henderson G (2014) The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours. Psychopharmacology (Berl)","DOI":"10.1007\/s00213-014-3666-3"},{"key":"3995_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","volume":"60","author":"F Kiefer","year":"2003","unstructured":"Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kampf P, Stracke R, Baehr M, Naber D, Wiedemann K (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60:92\u201399","journal-title":"Arch Gen Psychiatry"},{"key":"3995_CR13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/alcalc\/agq065","volume":"45","author":"S Loeber","year":"2010","unstructured":"Loeber S, Duka T, Welzel Marquez H, Nakovics H, Heinz A, Mann K, Flor H (2010) Effects of repeated withdrawal from alcohol on recovery of cognitive impairment under abstinence and rate of relapse. Alcohol Alcohol 45:541\u2013547","journal-title":"Alcohol Alcohol"},{"key":"3995_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002130000479","volume":"151","author":"LD Middaugh","year":"2000","unstructured":"Middaugh LD, Bandy AL (2000) Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL\/6 mice. Psychopharmacology (Berl) 151:321\u2013327","journal-title":"Psychopharmacology (Berl)"},{"key":"3995_CR15","first-page":"1386","volume":"23","author":"P Monti","year":"1999","unstructured":"Monti P, Rohsenow D, Hutchison K, Swift R, Mueller T, Colby S, Brown R, Gulliver S, Gordon A, Abrams D (1999) Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 23:1386\u20131394","journal-title":"Alcohol Clin Exp Res"},{"key":"3995_CR16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1177\/0091270011421785","volume":"52","author":"PJ Nathan","year":"2012","unstructured":"Nathan PJ, Bush MA, Tao WX, Koch A, Davies KM, Maltby K, O'Neill BV, Napolitano A, Skeggs AL, Brooke AC, Richards DB, Williams PM, Bullmore ET (2012a) Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the mu-opioid receptor inverse agonist GSK1521498. J Clin Pharmacol 52:1456\u20131467","journal-title":"J Clin Pharmacol"},{"key":"3995_CR17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0091270011399577","volume":"52","author":"PJ Nathan","year":"2012","unstructured":"Nathan PJ, O'Neill BV, Bush MA, Koch A, Tao WX, Maltby K, Napolitano A, Brooke AC, Skeggs AL, Herman CS, Larkin AL, Ignar DM, Richards DB, Williams PM, Bullmore ET (2012b) Opioid receptor modulation of hedonic taste preference and food intake: a single-dose safety, pharmacokinetic, and pharmacodynamic investigation with GSK1521498, a novel mu-opioid receptor inverse agonist. J Clin Pharmacol 52:464\u2013474","journal-title":"J Clin Pharmacol"},{"key":"3995_CR18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","volume":"28","author":"DW Oslin","year":"2003","unstructured":"Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546\u20131552","journal-title":"Neuropsychopharmacology"},{"key":"3995_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0091-3057(92)90373-N","volume":"41","author":"LA Parker","year":"1992","unstructured":"Parker LA, Rennie M (1992) Naltrexone-induced aversions: assessment by place conditioning, taste reactivity, and taste avoidance paradigms. Pharmacol Biochem Behav 41:559\u2013565","journal-title":"Pharmacol Biochem Behav"},{"key":"3995_CR20","unstructured":"Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, San Diego"},{"key":"3995_CR21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/01.jcp.0000245566.52401.20","volume":"26","author":"HM Pettinati","year":"2006","unstructured":"Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA (2006) The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol 26:610\u2013625","journal-title":"J Clin Psychopharmacol"},{"key":"3995_CR22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1530-0277.1997.tb03824.x","volume":"21","author":"TJ Phillips","year":"1997","unstructured":"Phillips TJ, Wenger CD, Dorow JD (1997) Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL\/6J mice. Alcohol Clin Exp Res 21:691\u2013702","journal-title":"Alcohol Clin Exp Res"},{"issue":"826\u201335","key":"3995_CR23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/mp.2011.83","volume":"16","author":"EA Rabiner","year":"2011","unstructured":"Rabiner EA, Beaver J, Makwana A, Searle G, Long C, Nathan PJ, Newbould RD, Howard J, Miller SR, Bush MA, Hill S, Reiley R, Passchier J, Gunn RN, Matthews PM, Bullmore ET (2011) Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Mol Psychiatry 16(826\u201335):785","journal-title":"Mol Psychiatry"},{"key":"3995_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1601-183X.2006.00210.x","volume":"6","author":"JS Rhodes","year":"2007","unstructured":"Rhodes JS, Ford MM, Yu CH, Brown LL, Finn DA, Garland T Jr, Crabbe JC (2007) Mouse inbred strain differences in ethanol drinking to intoxication. Genes Brain Behav 6:1\u201318","journal-title":"Genes Brain Behav"},{"key":"3995_CR25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1476-5381.2011.01406.x","volume":"164","author":"TL Ripley","year":"2011","unstructured":"Ripley TL, Stephens DN (2011) Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal. Br J Pharmacol 164:1335\u20131356","journal-title":"Br J Pharmacol"},{"key":"3995_CR26","doi-asserted-by":"crossref","unstructured":"Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev: CD001867","DOI":"10.1002\/14651858.CD001867.pub3"},{"key":"3995_CR27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00008877-200009000-00004","volume":"11","author":"DN Stephens","year":"2000","unstructured":"Stephens DN, Dunworth SJ (2000) Previous experience of diazepam withdrawal prevents the formation of a withdrawal-conditioned taste aversion: test of a blocking hypothesis. Behav Pharmacol 11:471\u2013481","journal-title":"Behav Pharmacol"},{"key":"3995_CR28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876\u2013880","journal-title":"Arch Gen Psychiatry"},{"key":"3995_CR29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/mp.2012.154","volume":"18","author":"H Ziauddeen","year":"2013","unstructured":"Ziauddeen H, Chamberlain SR, Nathan PJ, Koch A, Maltby K, Bush M, Tao WX, Napolitano A, Skeggs AL, Brooke AC, Cheke L, Clayton NS, Sadaf Farooqi I, O'Rahilly S, Waterworth D, Song K, Hosking L, Richards DB, Fletcher PC, Bullmore ET (2013) Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects. Mol Psychiatry 18:1287\u20131293","journal-title":"Mol Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-015-3995-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-3995-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-3995-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T19:50:07Z","timestamp":1566935407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-015-3995-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,5]]},"references-count":29,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["3995"],"URL":"https:\/\/doi.org\/10.1007\/s00213-015-3995-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,5]]}}}